The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLEK.L Regulatory News (LEK)

  • There is currently no data for LEK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

16 May 2022 07:00

RNS Number : 5278L
Lekoil Limited
16 May 2022
 

16 May 2022

Lekoil Limited

("LEKOIL" or the "Company")

Notice of application for admission to the Aquis Stock Exchange and Cancellation of Admission to trading on AIM

LEKOIL (AIM: LEK), announces that it has applied for admission of its Ordinary Shares to trading on the Access segment of the AQSE Growth Market operated by the Aquis Stock Exchange (AQSE). It is expected that admission will occur on 18 May 2022 and that trading will commence on AQSE as soon as the audited accounts for the Company are released to the market, expected to be by the end of June 2022.

 

The Company's Ordinary Shares have been suspended from trading on AIM since October 2021. Pursuant to AIM Rule 41, admission of the Company's shares to trading on AIM will be cancelled with effect from 7.00 a.m. on 18 May 2022 with the Company's shares being admitted to trading on the AQSE Growth Market from this time.

Moving from AIM to AQSE will not affect a shareholder's legal or beneficial right to his or her shares. Shareholders are not required to take any action at this stage.

 

Anthony Hawkins, Interim Executive Chairman, commented:

"The Board of the Company considers AQSE to be a suitable exchange to provide for the continued listing of its shares.

The Board is of the view that the Company's primary activity is now the recovery of its investment through litigation against the Lekoil Nigeria group and Mr. Akinyanmi. This characterisation will allow the Company to fulfil its disclosure obligations to the AQSE market, noting that a successful recovery of the intercompany debts due to the Company will be the primary source of value for shareholders (with minimal value attributable to the day-to-day operational activities of Lekoil Nigeria).

With respect to the suspension of the Company's shares from trading on AQSE, the Company has a clear understanding as to what is required to restore trading in the Company's shares on AQSE and we are diligently working through that plan. We will update our shareholders on this matter as soon as is practicable.

In selecting the AQSE Growth Market, the Board was keen to provide shareholders with the services of a regulated SME Growth market and a trading facility while it pursues its litigation assets, and its strategy unfolds."

 

With effect from the cancellation of the admission of the Company's shares to trading on AIM SP Angel Corporate Finance LLP will cease to act as Nominated Adviser and joint broker to the Company.

 

The Company's shares will continue to be registered with the existing ISIN number KYG5462G1073 and SEDOL number B9FFQF9. The Company's ticker symbol will continue to be LEK.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

For further information, please visit www.lekoilplc.com or contact:

Lekoil Limited

Anthony Hawkins

 

info@lekoilplc.com

SP Angel Corporate Finance LLP (AIM Nominated Adviser and Joint Broker)

Jeff Keating / Stuart Gledhill

 

+44 20 3470 0470

First Sentinel Corporate Finance Limited (AQSE Corporate Adviser)

Brian Stockbridge

 

+44 20 3989 2200

Tennyson Securities (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 20 7186 9030

Camarco (Financial PR Advisor)

Billy Clegg / Owen Roberts / Violet Wilson

+44 20 3757 4983

  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDAAMLTMTIBMAT
Date   Source Headline
20th Jun 20167:00 amRNSOperations & Debt Financing Update
7th Jun 20163:14 pmRNSHolding(s) in Company
13th Apr 20167:00 amRNSOtakikpo Operations Update
17th Mar 20167:00 amRNSLekoil Presentation at UBS Conference
3rd Mar 20164:43 pmRNSHolding(s) in Company
6th Jan 20164:40 pmRNSSecond Price Monitoring Extn
6th Jan 20164:35 pmRNSPrice Monitoring Extension
24th Dec 201510:11 amRNSAward of options
3rd Dec 20158:45 amRNSOperations Update and Analyst & Investor Day
3rd Dec 20157:00 amRNSHolding(s) in Company
1st Dec 20157:00 amRNSAcquisition of Afren's Interest in OPL 310
16th Nov 201512:45 pmRNSResult of General Meeting
2nd Nov 20154:26 pmRNSHolding(s) in Company
2nd Nov 201510:25 amRNSHolding(s) in Company
2nd Nov 20157:00 amRNSPosting of Circular and Notice of EGM
28th Oct 20158:41 amRNSCompletion of Placing
27th Oct 20156:26 pmRNSAcquisition and Proposed Placing
30th Sep 20157:00 amRNSHalf Yearly Report
25th Sep 20157:00 amRNSNotice of Half Yearly Results
7th Sep 20157:00 amRNSFirst oil from Otakikpo
29th Jul 20157:01 amRNSOtakikpo Operational Update
7th Jul 20154:35 pmRNSPrice Monitoring Extension
30th Jun 20157:00 amRNSAppointment of Non-Executive Director
29th Jun 20157:00 amRNSDirectorate Change
26th Jun 20151:44 pmRNSResult of AGM
25th Jun 20157:00 amRNSDirector/PDMR Shareholding
16th Jun 20157:00 amRNSReceipt of Ministerial Consent for Otakikpo
4th Jun 201511:20 amRNSEBT Share Sale and Director Dealing
29th May 20157:00 amRNSPosting of Annual Report and Notice of AGM
19th May 20152:08 pmRNSDirector's Dealing
11th May 20157:01 amRNSChange of Adviser
11th May 20157:00 amRNSFinal Results
7th May 201512:04 pmRNSExercise of Options and Total Voting Rights
12th Mar 20154:40 pmRNSSecond Price Monitoring Extn
12th Mar 20154:35 pmRNSPrice Monitoring Extension
10th Mar 20154:35 pmRNSPrice Monitoring Extension
22nd Jan 201511:36 amRNSDirector/PDMR Shareholding
21st Jan 20157:00 amRNSResource to Reserve Conversion at Otakikpo
16th Dec 20147:00 amRNSOtakikpo Project Update
11th Dec 20147:00 amRNSDirector Loan
5th Dec 20144:40 pmRNSSecond Price Monitoring Extn
5th Dec 20144:35 pmRNSPrice Monitoring Extension
8th Oct 20142:30 pmRNSStatement re. Press Comment
30th Sep 20147:00 amRNSHalf Yearly Report
23rd Sep 20147:00 amRNSOtakikpo CPR
15th Sep 20142:30 pmRNSPresentation at Investor Forum
5th Aug 201410:10 amRNSHolding(s) in Company
4th Jul 201410:32 amRNSHolding(s) in Company
30th Jun 20147:00 amRNSDirectorate Change
20th Jun 20144:22 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.